CCCC vs VNO
C4 Therapeutics Inc (CCCC) versus VNO (VNO) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
VNO (VNO) common stock.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
VNO does not have a complete income-statement cache yet.
CCCC currently screens at market cap $425.7M. VNO currently screens at market cap $0.
Not investment advice. Open the CCCC and VNO stock pages for the full models.
Not investment advice.